mRNA-engineered T cells against telomerase: a novel immunotherapy approach for cancer

Authors

  • Mudasir Maqbool Department of Pharmacology, Government Medical College, Kanth Bagh, Baramulla 193101, Jammu and Kashmir, India. Email: bhatmudasir92@gmail.com https://orcid.org/0000-0002-9036-008X
  • Zulfkar Qadrie Department of Pharmacology, Government Medical College, Kanth Bagh, Baramulla 193101, Jammu and Kashmir, India https://orcid.org/0000-0001-8886-6308
  • Amita Joshi Rana College of Pharmacy, Graphic Era Hill University, Bhimtal, Uttarakhand 263136, India https://orcid.org/0000-0003-1907-4459
  • Sumel Ashique Department of Pharmaceutical Technology, Bharat Technology, Uluberia-711316, West Bengal, India. https://orcid.org/0000-0003-4362-2830
  • Md Sadique Hussain Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Prem Nagar, Dehradun, Uttarakhand 248007, India. https://orcid.org/0000-0002-3554-1750

DOI:

https://doi.org/10.17179/excli2025-8327

Keywords:

Adoptive Cell Transfer, Cancer Immunotherapy, Gene Expression, T-Cell Receptors, T-Lymphocytes, Telomerase, Tumor Microenvironment

Published

2025-05-28

How to Cite

Maqbool, M., Qadrie, Z., Rana, A. J., Ashique, S., & Hussain, M. S. (2025). mRNA-engineered T cells against telomerase: a novel immunotherapy approach for cancer. EXCLI Journal, 24, 570–572. https://doi.org/10.17179/excli2025-8327

Issue

Section

Letters to the editor

Categories

Most read articles by the same author(s)